VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 12, 2006--Dr. John Todd, President and CEO of ProtoKinetix, Inc. (OTCBB:PKTX - News), announces that the Company has entered into an agreement with the University of Bordeaux to conduct third party evaluations on UV protection provided by AAGP(TM). The University of Bordeaux, France, is recognized as one of the world’s leading institutions in the study of UV protection. ProtoKinetix has, to date, completed extensive testing on human skin cells using the extremely harsh UV-C radiation. As previously reported, PKTX has received definitive confirmation of AAGP(TM) protection against UV-C.
